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Anaesthesia for Patients with 
Pericardial Disease
Michelle Correia
Abstract
Patients with pericardial disease can present to the anaesthesiologist for a variety 
of diagnostic procedures or therapeutic interventions. Providing safe anaesthesia 
care for these patients is challenging because of their primary pericardial pathol-
ogy and significant co-morbidities affecting other organ systems. A thorough 
understanding of the pathophysiology of the pericardial disease state and its 
effect on overall haemodynamic variables is necessary before formulating a peri-
operative care plan. A multidisciplinary approach involving cardiology, surgical, 
anaesthesia and critical care teams is needed to provide optimal peri-operative 
care. This chapter examines the basic pathophysiology of pericarditis, pericardial 
effusions, tamponade and constrictive pericarditis as these conditions pertain to the 
anaesthesiologist in the peri-operative period. Diagnostic tools, especially the role 
of echocardiography, that aid in the diagnosis and management of these high-risk 
patients are highlighted.
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1. Introduction
Patients with pericardial disease can present to the anaesthesiologist for a variety 
of diagnostic procedures or therapeutic interventions. Providing safe anaesthesia 
care for these patients is challenging because of their primary pericardial pathology 
and significant co-morbidities affecting other organ systems. A thorough under-
standing of the pathophysiology of the pericardial disease state and its effect on 
overall haemodynamic variables is necessary before formulating a peri-operative 
care plan. A multidisciplinary approach involving cardiology, surgical, anaesthesia 
and critical care teams is needed to provide optimal peri-operative care.
This chapter will examine the basic physical and physiological principles that 
govern the pathological states of pericarditis, pericardial effusion, tamponade and 
constrictive pericarditis. A thorough understanding of these principles is required 
prior to the induction of anaesthesia.
2. Normal anatomy and physiology
2.1 Normal anatomy
The normal pericardium is situated in the anterior mediastinum surround-
ing the heart and proximal portions of the great vessels [1–7]. It is composed of 
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two layers: an inner visceral layer which is thin, adherent to and continuous with 
the epicardium of the heart and an outer parietal layer which is thicker and more 
fibrous. Normal pericardial thickness is 1–2 mm [8]. The parietal and visceral 
layers are separated by a small amount of serous fluid [1–8]. In non-disease states, 
approximately 15–50 ml of fluid is contained within the pericardial sac. This fluid 
is produced by visceral mesothelium cells and is drained from the pericardial space 
via the lymphatic system to the right side of the heart.
The pericardium is fixed in its anatomical position to the diaphragm and ster-
num via the pericardio-phrenic and sterno-pericardial ligaments, respectively [4]. 
Posteriorly, the loosely bound connective tissue anchors it to structures contained 
within the posterior mediastinum.
Vascular supply is from the pericardio-phrenic artery which is a branch of the 
internal thoracic artery. Venous drainage is via the pericardio-phrenic veins which 
drain into the brachiocephalic veins bilaterally. The phrenic nerve provides sensory 
innervation and the sympathetic trunks’ vasomotor innervation [4].
The reflections of the pericardium surrounding the great vessels form two 
potential spaces called the oblique and transverse sinuses which can be visualised 
on echocardiographic imaging [4, 8]. The larger oblique sinus forms posteriorly 
between the left atrium and pulmonary veins. The transverse sinus too lies behind 
the left atrium, posterior to the aorta and pulmonary trunk [4]. Both sinuses are 
common sites for blood to collect post-cardiac surgery. Because of the formation of 
these two sinuses, the left atrium is not entirely an intra-pericardial structure.
2.2 Normal physiology and functions of the pericardium
Although normal cardiovascular function can occur in the absence of the peri-
cardium, it does bestow certain physiological benefits [1–8]. Because of its relatively 
fixed ligamentous attachments, the pericardium stabilises the heart in its anatomic 
position and limits excessive movement within the chest cavity particularly with 
changes in body position. The pericardial fluid minimises friction exerted on the 
epicardium from normal heart movements during the cardiac cycle and serves to 
balance hydrostatic pressures over the surface of the heart. The pressure exerted 
on the cardiac chambers by the pressure within the intra-pericardial space prevents 
acute distention of the chambers and helps optimise atrial and ventricular coupling 
and filling. The pericardial sac serves as a physical barrier against the spread of 
infection or neoplastic disease within the mediastinum. Prostaglandins secreted 
by mesothelial and endothelial cells of the pericardium regulate autonomic cardiac 
reflexes, modulate myocardial contractile function and influence epicardial coro-
nary artery tone.
3. Pathology
There are a number of pericardial pathologies which can be a cause for concern 
in the peri-operative period [2–4, 9, 10].
3.1 Congenital defects
Congenital defects are rare, usually associated with other cardiac, pulmonary 
and skeletal abnormalities, and are often only found at autopsy with an incidence 
of 1:10,000 [9]. The absence of the pericardium is more commonly partial with 
the left side being affected about 70% of the time. Left-sided defects predispose to 
herniation of the heart which may become haemodynamically significant during 
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induction of anaesthesia or cause prolonged ischaemia due to compression of the 
coronary vessels. Right-sided defects may cause significant compression of the vena 
cava compromising venous return and cardiac output. Total pericardial absence is 
rare. Excessive cardiac motion and displacement associated with complete absence 
predispose to an increased risk of traumatic aortic dissection.
3.2 Acute pericarditis
Acute pericarditis is an inflammatory disease of the pericardium lasting less than 
6 weeks and the most common pericardial pathology encountered in clinical prac-
tice [6, 9–16]. It may be a self-limiting benign condition or the first presentation of 
an underlying infectious or neoplastic disease process. In this setting, it is prudent 
to postpone elective surgery for diagnosis and initiation of appropriate treatment.
Causes of acute pericarditis vary widely and may be idiopathic, infectious, 
non-infectious or autoimmune. The most common causes encountered in the peri-
operative period are non-infectious post-cardiac surgery, associated with trauma, 
uraemia in patients with chronic renal failure or post-myocardial infarction.
Symptoms include a sharp left precordial or retrosternal chest pain which may 
be pleuritic in nature and varies with posture, being decreased on sitting and 
increased on lying supine. The pain may radiate to the trapezius ridge. This pain 
referral is due to the involvement of the phrenic nerve which traverses the pericar-
dium and supplies its sensory innervation. Often there are associated prodromal 
symptoms of malaise, fever and generalised myalgia. Tachycardia and tachypnoea 
are usually out of proportion to the low grade fever. A tri-phasic friction rub corre-
sponding to atrial systole, ventricular systole and rapid early filling during diastole 
may be present on examination.
In the peri-operative period, differentiating between acute pericarditis and other 
causes of chest pain is of utmost importance. Careful clinical examination and spe-
cial investigations should be carried out to make the correct diagnosis and allow for 
the institution of appropriate treatment. Three of the more important differential 
diagnoses are acute coronary syndrome, aortic dissection and pulmonary embolism.
Patients suffering from pericarditis associated with bacterial or fungal infec-
tions, malignancies, end-stage renal disease or post-cardiac surgery are at an 
increased risk to progress to pericardial effusion and tamponade [12].
Post-cardiac injury syndromes, also known as post-pericardiotomy syndromes, are 
being recognised as an important cause for pericardial disease [13, 14]. This clinical 
syndrome is characterised by a febrile illness associated with pleuritic chest pain 
and effusions of the pleura and pericardium. The initiating event is an injury to 
the pericardium, myocardium and pleura from ischaemia, post surgery or a non-
iatrogenic traumatic event. In predisposed individuals, an autoimmune-mediated 
response is triggered that can vary from a simple, self-limiting pericarditis to a 
complicated pleuropericarditis, resulting in massive pericardial and pleural effu-
sions with tamponade.
Special investigations would include a 12-lead electrocardiogram (ECG) which 
will show sinus tachycardia, PR interval depression and diffuse concave upward 
sloping ST-segment elevation. Transthoracic echocardiography (TTE) may show 
an associated pericardial effusion and tamponade as well as other cardiac or para-
cardiac diseases.
Treatment for acute pericarditis remains symptomatic with non-steroidal 
anti-inflammatory drugs (NSAIDs) for pain and potentially adding colchicine as 
an adjunct to prevent recurrence [15]. Low-dose corticosteroids may also be intro-
duced by the primary care team if there is an associated autoimmune disease or in 
the case of a post-cardiac injury syndrome [13, 14, 16].
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3.3 Chronic pericarditis
Chronic pericarditis may be a result of the progression of acute disease or due to 
recurrent episodes of relapse [6, 9, 10]. The peri-operative management will depend 
on haemodynamic consequences the disease process has on patient physiological 
parameters.
Differentiation should be made between chronic pericarditis with ongoing 
inflammation, pain and fever, relapsing disease where patients have periods of 
being symptom free and chronic pericardial effusion with persistent fluid accumu-
lation within the pericardial sac.
As with acute pericarditis, all elective surgery should be postponed to enable 
symptomatic treatment of attacks with NSAIDs, colchicine and corticosteroids. 
Pericardiectomy is indicated in patients with frequent and severe symptoms that are 
unresponsive to maximal medical therapy [6, 9].
Chronic inflammatory disease may be associated with a pericardial effusion. 
Moderate to large effusions, determined at echocardiography as being more than 
10 mm separation of the pericardial layers during diastole, should be drained before 
any elective surgery takes place. Haemodynamic effects of the effusion should be 
assessed via echocardiographic studies and quantified prior to induction of anaes-
thesia as detailed below.
3.4 Pericardial effusions and tamponade
Pericardial effusion occurs when there is excessive fluid accumulation within 
the pericardial space [3–10, 12, 17–41]. The effusion may be transudative, exuda-
tive, haemorrhagic or purulent depending on the cause. Progressive accumulation 
of fluid within the pericardial sac may lead to compression of cardiac chambers, 
obstruction of cardiac filling and tamponade.
3.4.1 Causes for effusion
Causes of pericardial effusion are similar to those for pericarditis and may be 
due to the inflammatory process itself [6, 16, 18–21]. The most common causes of 
pericardial effusion seen in the peri-operative period are iatrogenic, associated with 
cardiac surgery or percutaneous coronary intervention (PCI); traumatic as seen in 
blunt or penetrating chest injuries; associated with malignancy; as a consequence of 
end-stage renal disease or dialysis; and those occurring from infectious diseases. In 
developing countries, especially where the prevalence of HIV is high, tuberculous 
pericarditis is common [6, 17].
There are a few groups of patients that require special mention as they fre-
quently need intervention by the anaesthesiology team and present with pericardial 
effusions in the peri-operative period.
3.4.1.1 End-stage renal disease
Patients with end-stage renal disease (ESRD) frequently present to the anaes-
thesiologist for a number of diagnostic, therapeutic or vascular access procedures 
[6, 18–21]. The association with end-stage renal and cardiovascular disease is well 
established. Increased inflammatory processes, immune and autoimmune dysfunc-
tion, dyslipidaemia, endocrine abnormalities, oxidative stress and accumulation of 
toxic metabolites have all been suggested as causes for this association. This popula-
tion is known to have an increased incidence of coronary artery disease, valvular 
pathology, arrhythmias and myocardial and pericardial diseases [18].
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The incidence of pericarditis in ESRD is 2–21% with effusion and tamponade 
being present in up to 14–56% of patients. The aetiology differs between patients on 
haemodialysis and those who are not. Patients not yet on haemodialysis develop a 
uraemic pericarditis and effusions that generally respond well to aggressive dialysis 
and filtration. The incidence of uraemic pericarditis is decreasing because of more 
efficient dialyzer membranes and methods.
Patients on haemodialysis develop dialysis pericarditis with effusions that more 
frequently require drainage via a pericardial window procedure. This group of 
patients has a higher incidence of progressing to constrictive pericarditis possibly 
requiring pericardiectomy [18]. Progression from effusion to tamponade may be 
difficult to diagnose, but progressive right heart failure and hypotension in the 
setting of adequate diuresis is highly suggestive [18]. All patients with ESRD pre-
senting for surgery should have pre-operative investigations to rule out significant 
pericardial disease that may impact on peri-operative management.
Indications for drainage of effusions in these patients are based on clinical 
and biochemical features. Dialysis pericarditis, tachypnoea >20 breaths/min, 
fever >39°C, low voltage complexes on 12-lead ECG, hypoalbuminaemia <31 g/l, 
leukocytosis and any signs of tamponade on TTE all indicate the need for drainage 
[18]. There are little data to support one drainage procedure over another [6, 18]. 
Pericardiocentesis and pericardial window are both acceptable methods for relief of 
raised intra-pericardial pressure.
Although these patients may exhibit signs of large effusions and even tampon-
ade, significant haemodynamic compromise associated with anaesthesia is rare 
in this group of patients. Because of the chronicity of the disease process and the 
associated hypertension, careful titration of agents used for general anaesthesia to 
facilitate drainage procedures is usually well tolerated [21].
3.4.1.2 Post-cardiac surgery and post-operative pericardial effusions (PPE)
Patients post-cardiac surgery are another group whose management frequently 
requires the involvement of the anaesthesiology team [24, 32–38]. Accumulation 
of blood within the pericardial sac because of ongoing bleeding from either a 
surgical or medical cause peri-operatively will lead to the development of PPE 
and tamponade. PPE can be divided into early, presenting within 7 days, and late 
complications occurring more than 7 days post-procedure. An important cause of 
persistent PPE is the inflammatory response associated with post-cardiac injury 
syndrome [13, 14, 33].
The incidence for PPE has a wide range depending on the study quoted and is 
approximately 20% on the 20th post-operative day [33]. Most effusions are clini-
cally insignificant, defined as less than 10 mm in diastole on TTE, and resolve 
spontaneously after reaching their maximum volume on day 10 post-operatively 
[33]. The incidence of significant pre-tamponade and tamponade requiring 
 re-intervention is 1–2.6% [33].
Presenting symptoms are usually non-specific consisting of tachycardia, 
hypotension, tachypnoea, orthopnoea and decreased heart sounds [24, 32–34]. 
This low cardiac output state must be differentiated from other common causes of 
cardiogenic shock in the post-operative period. The differential diagnosis would 
include hypovolaemia, significant ischaemia, ventricular dysfunction or severe 
inflammatory response syndrome [32].
The following have been identified as independent risk factors for the develop-
ment of post-operative effusions [33, 34, 37]: heart transplantation, pulmonary 
thromboembolism, aortic aneurysm surgery, increased body surface area, valve 
surgery, immunosuppression, urgent or emergent surgery, renal failure and 
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prolonged cardiopulmonary bypass (CPB) times. In other studies, female gender, 
pre-operative use of anticoagulants and early chest drain removal have been associ-
ated with increased incidence of PPE [33, 37].
In the setting of post-operative haemodynamic deterioration, critical tamponade 
may develop quickly with even small amounts of fluid accumulation causing signifi-
cant haemodynamic effects. The diagnosis should be made immediately in order to 
facilitate life-saving intervention. TTE remains the diagnostic tool of choice because 
it is non-invasive and has a high sensitivity and specificity for detecting the signs of 
cardiac tamponade [6, 24, 32, 35, 38]. It may also be useful in confirming or ruling 
out other causes for post-operative haemodynamic deterioration. Because tampon-
ade is a dynamic pathological process, especially in the post-operative period, serial 
or repeat echocardiographic examinations coupled with ongoing clinical evaluation 
are necessary to ensure appropriate and timeous management.
Although TTE remains the diagnostic tool of choice, detecting effusions and 
tamponade post-operatively may be challenging [31, 32, 38]. Patients who have 
altered anatomy are most likely to be on positive pressure ventilation with positive 
end expiratory pressure (PEEP), may have pneumopericardium (air trapped in the 
pericardium) and will have drains in situ. Effusions post cardiac surgery are often 
loculated causing regional compression of only one or some of the cardiac chambers. 
Blood and clots collect in the posterior sinuses making diagnosis via the traditionally 
accepted criteria on TTE difficult. Trans-oesophageal echocardiography (TOE) is 
well tolerated in sedated or anaesthetised patients but is more invasive and may not 
be readily available. Supplemental modalities such as CT scan and cardiac MRI have 
been suggested to aid in the diagnosis when TTE is inconclusive [6, 31, 38].
Indications for drainage of effusions are based on clinical and TTE findings of 
tamponade: left ventricular dysfunction in patients receiving intermittent posi-
tive pressure ventilation, loculated effusions or clots causing compression of the 
left atrium or left ventricle, documented collapse of right-sided chambers and if 
pericardial separation is >20 mm [3, 32, 35].
Anaesthetic management of post-operative effusions and tamponade remains 
the same as for an effusion from any other cause. The need for ongoing inotropic 
support and appropriate mechanical ventilation, massive fluid shifts, ongoing 
bleeding due to surgical causes, coagulopathy due to anticoagulant use, intrinsic 
clotting abnormalities, need for massive blood transfusion, renal dysfunction and 
the significant risks of re-sternotomy are just a few of the unique challenges for 
the anaesthesiologist to consider when taking a cardiac patient back to theatre for 
re-intervention. Drainage procedures are most often limited to pericardiocentesis 
under ultrasound- or video-assisted guidance [25, 32, 35]. A small percentage of 
patients may require sternotomy for the effective management of post-operative 
effusions [25, 32].
3.4.1.3 Effusions in patients undergoing percutaneous cardiac interventions
Percutaneous intracardiac intervention is a risk factor for the development of 
pericardial effusion and tamponade [39–41]. The exact incidence depends on the 
procedure performed, the extent of the intervention, whether it is diagnostic or 
therapeutic, and if anticoagulation is used in the peri-procedural period. The exact 
procedure-specific incidence is difficult to determine, and small to moderate effu-
sions may occur much more frequently than studies suggest [39]. The incidence of 
tamponade ranges from <1 to 6% depending on the study being quoted. Some of the 
more commonly performed interventions include atrial fibrillation ablation associ-
ated with a 4% risk of tamponade, permanent pacemaker insertion which carries 
a 1.7% risk of cardiac perforation and life-threatening tamponade and left atrial 
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appendage (LAA) occlusion procedures which are associated with a 1.8–3% risk of 
tamponade, most commonly due to LAA perforation.
The overall incidence of tamponade following percutaneous coronary interven-
tion (PCI) is 0.12% and is associated with high mortality [40, 41]. Coronary artery 
perforation following percutaneous coronary intervention is found in 0.3% of 
patients of which 10% went on to develop tamponade [41]. The risks were increased 
in patients requiring more complex interventions and if athero-ablative procedures 
were performed instead of angioplasty and stent placement.
Pericardial effusion and tamponade following PCI usually present acutely in the 
catheterisation lab but can have an insidious onset and are an important cause for 
late hypotension post intervention [40].
The diagnosis of tamponade post PCI remains predominately clinical and should 
be confirmed with TTE and other imaging techniques as soon as possible in order to 
facilitate life-saving treatment drainage procedures as described below.
3.4.2 Pathophysiology of pericardial effusions
The haemodynamic effects of the effusion and the development of tamponade 
are dependent on the rate of fluid accumulation within the pericardial space, the 
total volume of fluid that accumulates, the type of the fluid that accumulates and 
the intrinsic compliance of the pericardial tissue layers [4, 5, 7, 24].
Because the pericardium is relatively stiff, it has a limited reserve volume. Small 
but rapidly accumulating effusions quickly exceed the compliance of the parietal 
layer. Once the limit of pericardial stretch is exceeded, even small increases in 
volume cause a steep increase in pericardial pressure causing external compression 
of the cardiac chambers and tamponade.
Chronic accumulation over a prolonged period allows for pericardial stretch and 
compensatory mechanisms meaning that the intra-pericardial pressure remains 
low despite a large amount of fluid within the space. Even with additive amounts of 
fluid, the pericardial compliance curve remains less steep than in the acute setting 
resulting in slower increases in intra-pericardial pressures relative to the volume of 
fluid within the space.
The type of fluid that accumulates may influence the haemodynamic presenta-
tion. Exudative fluid may become fibrinous and cause constriction, haemorrhagic 
fluid may contain clots causing isolated chamber compression and chronic effusions 
may become fibrotic and confining.
The compliance of the pericardial tissues is also an important determining factor in 
the overall haemodynamic effects of an effusion. Pericardial compliance is decreased 
in mesothelioma, scarring from previous cardiac surgery and constrictive states.
Once intra-pericardial and intracardiac pressures increase beyond a certain 
limit, cardiac chamber filling and preload are reduced which causes a drop in stroke 
volume and cardiac output. This decrease in cardiac output causes a reduction in 
organ perfusion which triggers compensatory mechanisms including activation 
of the sympathetic nervous system and the renin-angiotensin-aldosterone axis. 
The resultant tachycardia, peripheral vasoconstriction and fluid retention are an 
attempt to maintain systemic blood pressure and organ perfusion in the face of a 
low cardiac output state.
3.5 Tamponade
Tamponade physiology occurs when cardiac chambers exhibit compression due 
to an increase in intra-pericardial pressures and equalisation of transmural pres-
sures [3–10, 14–17, 22–24].
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3.5.1 Causes of tamponade
Patients most at risk for the development of tamponade are those with iatrogenic 
causes post-cardiac surgery, PCI, insertion of pacemaker or percutaneous valve 
repair, chest trauma where blunt injuries are five times more commonly associated 
with tamponade when compared with penetrating injuries [25], malignant disease 
which is the most common cause of cardiac tamponade accounting for up to 60% of 
cases [25] and ESRD. Uraemic disease accounts for 10–15% of cases, while the inci-
dence of dialysis pericarditis is 12% in patients on long-term haemodialysis [18–21].
3.5.2 Pathophysiology of cardiac tamponade
Under normal circumstances, intra-pericardial pressures reflect intrathoracic 
pressures and are negative [3–10, 12, 21–31]. As fluid accumulates within the 
pericardial space, the intra-pericardial pressures increase. Pericardial pressures are 
elevated throughout the cardiac cycle and cause compression of chambers for the 
duration of diastole when intracardiac chamber pressures are lowest.
Impaired filling of the cardiac chambers leads to diastolic dysfunction and a type 
of obstructive shock [23]. The venous return pattern to the atria eventually becomes 
unimodal and is confined to ventricular systole. In severe tamponade, atrial filling 
only occurs when ventricular contraction forces the atrioventricular valvular appa-
ratus towards the myocardial apex. This caudad motion of the tricuspid and mitral 
valves causes a decrease in atrial pressures and enhanced systemic and pulmonary 
venous return.
As tamponade physiology progresses, ventricular filling becomes highly depen-
dent on atrial systole as the intra-pericardial pressures increase. The maintenance 
of a sinus cardiac rhythm becomes paramount to ensure adequate ventricular filling 
to maintain end-diastolic ventricular volumes which are equivalent to ventricular 
stroke volume.
Physiologically speaking, cardiac chamber filling pressures are dependent on 
the myocardial transmural pressure gradient expressed mathematically by the 
following:
  transmural pressure = intra-pericardial pressure − intracardiac pressure 
The intracardiac pressures are different for each chamber with right atrial pres-
sures being the lowest to facilitate systemic venous return.
Based on Ohm’s law (V = IR), in order to ensure filling and forward flow in a 
normal series circulation, there must be a pressure gradient (P1–P2 or V) between 
the systemic venous return and the aorta. The pressure gradients below are often 
seen during diagnostic cardiac catheterisation procedures when venous and arterial 
pressures are obtained and documented:
 systemic venous return pressure ➤ right atrial pressure ➤ right ventricular 
end-diastolic pressure ➤ right ventricular systolic pressure ➤ pulmonary capillary 
wedge pressure ➤ pulmonary venous return pressure ➤ left atrial pressure ➤ left 
ventricular end-diastolic pressure ➤ left ventricular systolic pressure ➤ aorta 
As the intra-pericardial pressure increases, extrinsic compression of the car-
diac chambers occurs. Compression causes the intracardiac chamber pressures to 
increase, and the transmural pressures begin to equalise. Right-sided filling pres-
sures during diastole are lower than the left and are the first to be equalled and then 
exceeded by the increasing intra-pericardial pressures.
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The right atrium and ventricle are compressed, right-sided chamber filling is 
compromised and the right atrial pressure, measured clinically as the central venous 
pressure (CVP), increases to try and maintain right ventricular filling. This causes 
a significant decrease in the venous return to the right heart as right atrial pressures 
exceed systemic venous return pressures.
A decrease in right atrial venous return leads to impaired right ventricular 
filling, an underloaded right ventricle which functions at the lower end of the 
Frank-Starling curve and a resultant decrease in right ventricular stroke volume. 
Reductions in right ventricular stroke volume translate into decreased flow through 
the pulmonary circulation with decreased pulmonary venous return to the left 
atrium. With continued increases in the intra-pericardial pressures, equalisation of 
left-sided pressures eventually transpires. This results in massive reductions in and 
eventual cessation of diastolic filling and forward flow of blood through the heart 
with dramatically reduced cardiac output.
A cycle of exhaustive physiological compensation follows with eventual 
cardiac arrest manifested as pulseless electrical activity. Although reductions in 
coronary blood flow do occur with the drop in cardiac output and aortic diastolic 
pressures, this is coupled with limited cardiac work, and ischaemia is usually 
avoided.
It is of utmost importance to note that the equalisation of transmural pressures 
found in cardiac tamponade is a dynamic process influenced by extra-cardiac 
factors. Induction of general anaesthesia causes a decrease in heart rate, vasodila-
tion and direct myocardial depression. Coupled with the institution of positive 
pressure ventilation, massive decreases in venous return and cardiac output occur. 
Thus, induction of anaesthesia may precipitate complete cardiovascular collapse in 
patients with tamponade.
Patients at risk for the development of tamponade should therefore have 
echocardiographic studies to confirm their pre-operative haemodynamic state. In 
the event of potential or imminent tamponade, all elective procedures should be 
postponed and the pericardium drained via the most appropriate method to relieve 
transmural pressures before induction of anaesthesia is performed.
3.5.3 Classification of tamponade
Not all cases of cardiac tamponade are uniform, and patients can present with 
different forms [24, 25].
Low-pressure tamponade occurs at very low diastolic pressures of 6–12 mmHg 
and is present in patients with severe hypovolaemia. Patients do not present with 
the full clinical picture of tamponade until they have been adequately fluid resusci-
tated and are fluid replete. This form is often found in trauma patients with ongoing 
haemorrhage or post-cardiac surgery.
Regional tamponade occurs when only specific cardiac chambers are compressed 
from localised amassing of fluid. This is a common finding post-cardiac surgery or 
myocardial infarction. Typical clinical findings of acute tamponade are often absent 
necessitating multimodal diagnostic imaging to make the diagnosis.
Hypertensive tamponade is said to be present when there are classical features of 
tamponade but with elevated arterial pressures, sometimes over 200 mmHg. It is 
thought to be due to excessive beta-adrenergic drive in patients with pre-existing 
hypertension.
Effusive-constrictive pericarditis is present when there is decreased pericar-
dial compliance with a reduced pericardial cavity associated with an effusion. 
Constrictive physiology is present, and tamponade can occur even with minimal 
amounts of fluid accumulation. A variety of haemodynamic and imaging signs 
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make for a mixed clinical picture. Drainage of the effusive fluid provides the best 
clue as symptoms of constriction persist in spite of appropriate drainage.
3.5.3.1 Clinical signs and diagnosis
Dyspnoea, orthopnoea, diaphoresis, chest pain and tachycardia are all non-
specific signs of pericardial effusion and tamponade. Muffled heart sounds, raised 
jugular venous pressure and hypotension are the features classically described as 
Beck’s triad used in the diagnosis.
Pulsus paradoxus is a clinical sign commonly found in tamponade and refers to 
the exaggeration of the normal physiological variation in systolic blood pressure 
of more than 10 mmHg during negative pressure ventilation. Under normal physi-
ological conditions, the intra-pericardial pressure mirrors intrathoracic pressures. 
Negative intrathoracic pressure generated on inspiration is transmitted to the heart, 
and the intra-pericardial pressure decreases. This in turn increases the transmural 
pressure gradient. The increase in transmural pressure gradient augments right 
atrial and ventricular filling during diastole. This is demonstrated on Doppler 
echocardiography by increased blood flow velocity across the tricuspid valve during 
inspiration [28].
The augmentation in right ventricular filling causes the intra-ventricular septum 
to shift to the left which transiently impacts on left ventricular filling. This is known 
as interventricular dependence. With normal pericardial pressures and compliance, 
compensation for this slight shift is maintained leading to minimal reductions in 
left ventricular end-diastolic volume. There is a small decrease in left ventricular 
stroke volume and cardiac output which results in a small decrease in systolic blood 
pressure during inspiration of not more than 10 mmHg. The augmented right 
ventricular stroke volume during inspiration translates into increased pulmonary 
venous return to the left atrium after several cardiac cycles. An increase in left ven-
tricular stroke volume and systolic blood pressure is then seen during expiration.
In cardiac tamponade, this normal systolic pressure variation with respiration 
is exaggerated. With the decrease in pericardial compliance, the normal pericardial 
compensation for the left heart shift is lost. As the intra-ventricular septum shifts 
to the left, the left heart cannot expand because of the increased intra-pericardial 
pressures. Left ventricular filling and flow through the left ventricular outflow tract 
are affected to a greater degree resulting in enhanced ventricular interdependence. 
This translates into a decrease of systolic blood pressure of more than 10 mmHg 
during inspiration.
Pulsus paradoxus is not very sensitive or specific for cardiac tamponade and may 
be absent even when tamponade is present or be present with conditions other than 
tamponade [22, 24, 25].
Pulsus may be absent in the presence of tamponade with severe aortic regurgita-
tion where left ventricular filling is maintained due to back flow from the aorta; 
with localised effusions or clot that compress only certain chambers of the heart; 
with an atrial septal defect where the pressure effect on the right atrium is balanced 
by the intra-cardiac shunt; and with severe right ventricular hypertrophy with pul-
monary hypertension where the pressure effects from increased intra-pericardial 
pressure on right heart are less pronounced.
Pulsus paradoxus may exist in the absence of tamponade in severe chronic 
obstructive pulmonary disease, asthma or severe bronchospasm, hypovolaemia, 
congestive cardiac failure and obesity.
Pulsus paradoxus will be reversed in patients receiving positive pressure ventila-
tion with increased systolic blood pressure noted on inspiration and a fall in systolic 
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blood pressure on expiration [22, 25]. This can be interpreted as systolic pressure 
variation in patients receiving mechanical ventilation which is often used clinically 
as a sign of fluid responsiveness.
Mechanical ventilation with PEEP has three main effects on cardiac physiology. 
(1) With the increase in intra-thoracic pressure, alveolar pressures increase more than 
pleural pressures which causes compression of pulmonary capillaries and increased 
right ventricular afterload. (2) Compression of pulmonary capillaries squeezes blood 
from the pulmonary bed into the left atrium augmenting left ventricular preload. (3) 
Positive inspiratory pressure augments left ventricular systolic function.
The augmentation of left ventricular stroke volume and systolic function during 
inspiration leads to increased systolic blood pressures. Pulmonary transit time is 
approximately 2 s, and the drop in right heart cardiac output from positive intratho-
racic pressures translates into a drop in left ventricular cardiac output and systolic 
blood pressure during expiration. A reversed pattern of pulsus paradoxus is seen.
As mentioned above, the combination of decreased venous return or preload to 
the right heart with induction of anaesthesia plus the increased right ventricular 
afterload effects of mechanical ventilation can severely compromise cardiac func-
tion in patients with tamponade.
3.5.3.2 Special investigations
Chest X-ray will show an enlarged globular bottle-shaped cardiac shadow if the 
pericardial fluid volume is >200 ml, a widened mediastinum with a right costo-
phrenic angle <90° and clear lung fluids [7–10, 12, 21–29]. There may be an associ-
ated pleural effusion that requires concurrent drainage and management.
ECG may show a sinus tachycardia which is the most common finding. Other 
findings may include low QRS and T wave voltages, PR segment depression, non-
specific ST-T wave changes and bundle branch block. Electrical alternans is the 
change in QRS voltage with each beat and reflects excessive swinging movement of 
the heart within a large effusion [21].
TTE is the investigation of choice to diagnose and evaluate pericardial disease 
[3–6, 12, 23–28, 30, 31]. It is a class 1 recommendation with a high sensitivity and 
specificity for the detection of effusions and tamponade. TTE in addition allows 
for the evaluation of myocardial and endocardial structures and function, aiding 
to rule out other causes for the clinical picture. A grading system for the size of the 
effusion is based on echo-free space in diastole with small effusions being <10 mm 
in size, moderate effusions 10–20 mm and large effusions >20 mm. Right atrial 
collapse and invagination for >30% of the cardiac cycle on ECHO is 100% sensitive 
for the diagnosis of tamponade [26].
Other TTE signs of tamponade include distention and loss of respiratory varia-
tion in the size of the IVC which reflects increased right atrial pressures, increased 
respiratory variations in tricuspid and mitral trans-valvular inflow velocities on 
Doppler studies, intra-ventricular septal shift reflected clinically as pulsus para-
doxus [26], localised or loculated effusions showing isolated chamber compression 
and regional tamponade commonly encountered post-cardiac surgery [32].
Cardiac catheterisation is usually not performed in acute tamponade as TTE is 
less invasive, less time-consuming and diagnostic. If catheterisation is performed, 
a blunted Y descent may be demonstrated [29]. The Y descent on the CVP tracing 
after the v wave indicates opening of the tricuspid valve and reflects early diastolic 
filling of the right ventricle. Attenuation of the y descent reflects rapid equalisa-
tion of pressures between the right atrium and ventricle which leads to ineffective 
ventricular filling during early diastole in tamponade (Figure 1).
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3.5.4 Medical management of pericardial effusions and tamponade
In about 60% of cases of pericardial effusion, an underlying disease process 
is known, and medical management would therefore be targeted at the aetiology 
[6]. In the absence of significant associated inflammation, NSAIDs, colchicine and 
steroids are generally ineffective, leaving no conservative management options for 
isolated effusions. In these instances, surgical drainage is indicated.
3.6 Constrictive pericarditis (CP)
Chronic inflammation of the pericardium causes it to thicken and become 
non-compliant and rigid [4, 6, 7, 9, 10, 12, 25, 31, 43–49]. This thickening may be 
concentric or regional depending on the cause. The pericardial space becomes oblit-
erated as the visceral and parietal layers change and stiffen. Restriction of cardiac 
chamber expansion during diastole causes impedance of cardiac filling and diastolic 
dysfunction at both the atrial and ventricular levels. The usual form is constriction 
without effusion but effusive-constrictive forms can occur.
3.6.1 Causes of constrictive pericarditis
Causes are similar to those for acute and chronic pericarditis including infectious 
disease, radiation to the mediastinum, trauma and autoimmune conditions [4, 13, 
14, 48, 49]. In the developing world, tuberculosis remains the most common cause 
with a prevalence of >90% in places where the HIV infection rates are high [49].
Post-cardiac surgery is the most common cause of CP in the peri-operative 
period. The usual presentation is constrictive pathophysiology with an increase in 
pericardial membrane thickness. However, constrictive pathophysiology may pres-
ent in the absence of pericardial membrane thickening [4, 48].
Post surgery, blood in the pericardial space causes a post-pericardiotomy-type 
picture with inflammation and adhesions [4, 13, 14]. These adhesions diminish the 
pericardial space and cause a constrictive pathophysiological picture in spite of 
normal pericardial thickness. This is termed normal thickness constrictive pericar-
ditis. In a Mayo Clinic study from 2003, 18% of patients with proven constriction 
who underwent pericardiectomy had a normal pericardial thickness of <2 mm on 
pre-operative imaging [48]. Disease of the pericardium in the normal thickness 
group consisted of mild focal areas of inflammation, calcification and fibrosis. The 
majority of patients were post-cardiac surgery and post chest irradiation or had 
suffered previous infective or idiopathic disease. Pericardiectomy was equally effec-
tive in relieving the disease symptoms in these patients compared with those who 
had a pericardial thickness > 2 mm. It would therefore seem reasonable to consider 
pericardiectomy in patients with a normal pericardial thickness if the endocardial 
biopsy is negative for restrictive cardiomyopathy [4, 48].
Figure 1. 
CVP tracing in cardiac tamponade reflecting higher baseline pressures and attenuation of the y descent.
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3.6.2 Pathophysiology of CP
Under normal circumstances, the pericardium can accommodate changes in 
cardiac volume [4, 6, 9, 12, 25, 43, 46, 47, 49]. With ongoing inflammation, the peri-
cardial compliance decreases. The now thickened, calcified and rigid pericardium 
encases the heart and limits cardiac chamber expansion during diastole. Initially, 
early diastolic filling is not affected, and the atrial contribution to ventricular filling 
is mostly impeded during mid- to late diastole.
Over time, diastolic filling becomes severely impaired, and the total blood 
volume within the heart remains relatively constant during diastole, leading to a 
fixed stroke volume state. Any increases in tissue perfusion demands must therefore 
be met by an increase in heart rate.
One of the most important features of CP is that changes in intrathoracic pres-
sures during the respiratory cycle are not transmitted to the heart. This is because 
the pericardial space has been destroyed by the inflammatory process and intra-
pericardial pressure no longer mirrors intrathoracic pressures [25]. This means that 
the normal augmentation of venous return to the right heart during inspiration does 
not occur. Lack of inspiratory decline in the jugular venous pressure leads rather to 
an increase in CVP with inspiration which is known as Kussmaul’s sign.
Respiratory variation in systolic blood pressures may still be seen clinically as the 
pulmonary veins lie outside of the pericardium and the left atrium is only partially 
within the pericardial sac. Changes in intrathoracic pressures will therefore still 
cause changes in pulmonary vein flow despite the uncoupling of intra-pericardial 
and intrathoracic pressures [4]. During negative pressure ventilation, inspiration 
will cause the pressure gradient between the pulmonary veins and the left ventricle 
to decrease, resulting in a decrease in LV filling and a small decrease in systolic 
blood pressure. This effect, however, is not enough to cause pulsus paradoxus.
Another important pathophysiological feature of CP is the dramatic increase in 
ventricular interdependence [45]. Pressure changes in one ventricle will be trans-
ferred to the other which explains the observed equilibration of diastolic ventricular 
pressures. This increase in ventricular coupling means that there is little, if any, 
trans-septal pressure gradient during diastole. Abnormal shifting of the intra-
ventricular septum has been observed in some studies but because the ventricles are 
operating at much higher baseline diastolic pressures, small changes in pressures 
caused by septal shift have very little effect on overall ventricular filling.
Chronic constriction of the myocardium can lead to damage of the underlying 
muscle tissue. Constriction causes the ventricles to operate at the lower end of the 
Frank-Starling curve which causes a kind of disuse atrophy within the myocardium. 
Myocardial atrophy may present with continued diastolic dysfunction coupled with 
significant systolic dysfunction even after successful pericardiectomy is performed 
and the myocardium is released. Often these patients will require ongoing inotropic 
support in the peri-operative setting.
3.6.2.1 Clinical signs and diagnosis
Signs and symptoms are usually non-specific and mimic right ventricular 
failure making diagnosis difficult [4, 6, 12, 25]. Tachycardia is the predominant 
sign because of the fixed stroke volume state. Arrhythmias, especially atrial 
fibrillation, are not uncommon. Fluid overload ranging from peripheral oedema 
to anasarca is a usual finding. This is due to venous hypertension which is often 
worsened by protein-losing enteropathy in decompensated disease. Patients may 
have associated pleural effusions and cachexia, indicating a chronic and insidious 
disease process.
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Decreased cardiac output with shortness of breath and fatiguability are almost 
always elicited on thorough enquiry. Ascites, hepatomegaly, pleural effusion and 
peripheral oedema can be misdiagnosed as chronic liver disease.
Classical clinical findings in CP include a pericardial knock and Kussmaul’s sign. 
A pericardial knock is a high-pitched sound occurring in early diastole before the 
third heart sound. It indicates the cessation of ventricular filling at the end of the 
early diastole due to the pericardial constriction.
Kussmaul’s sign is a paradoxical increase in jugular venous pressure on 
inspiration. It reflects an increase in right atrial preload from an increase in 
intra-abdominal pressure during inspiration. This increased venous return from 
the intra-abdominal veins is independent of intrathoracic pressure changes. The 
increase in preload cannot be accommodated because of the fixed pericardial 
constriction, and the back pressure is transmitted to the systemic venous system. 
This is detected clinically as increased pressure in the jugular vein.
The differential diagnosis for constrictive pericarditis is important to consider 
as clinical signs can be confusing. Restrictive cardiomyopathy, pulmonary embolus, 
right ventricular infarction, pleural effusion and chronic obstructive pulmonary 
disease can all have a similar clinical presentation.
3.6.2.2 Special investigations
The diagnosis of constrictive pericarditis remains challenging, and the clinical 
picture of unexplained venous congestion should be clarified with multiple imaging 
modalities to ensure accurate and efficient diagnosis [4, 6, 12, 25, 31].
Chest X-ray may show a ring of calcification around the heart and cardiomegaly 
if there is an associated effusion.
ECG may show low voltages, non-specific upward sloping ST-T wave changes, 
atrial fibrillation and P mitrale, indicating chronic atrial hypertension.
CT scan and MRI are both useful to confirm pericardial thickening and calcifica-
tion [4, 31]. CT scan can delineate and quantify the degree of calcification based on 
CT scan score, and MRI has a 93% accuracy for differentiating CP from restrictive 
cardiomyopathy based on a pericardial thickness of >4 mm.
TOE has a high sensitivity for the detection of features consistent with the diag-
nosis [12]. An increase in pericardial thickness > 2 mm, abrupt inspiratory posterior 
motion of the intra-ventricular septum in diastole and a non-pulsatile dilated IVC 
indicating venous hypertension are all expected echocardiographic features.
Pulsed wave Doppler on echocardiography can be used to assess the mitral 
trans-valvular inflow velocity pattern. Classically, an increase in the E wave velocity 
represents rapid early diastolic filling. Significant reductions in the A wave velocity 
represents decreased flow in mid- to late diastole. This indicates rapid early fill-
ing with premature equalisation of left atrial and left ventricular pressures from 
pericardial constriction.
Reverse pulmonary vein flow changes will be detectable as the poor left atrial 
compliance and raised left atrial pressures redirect flow back into the pulmonary 
veins. This results in decreased left atrial filling and decreased left ventricular end-
diastolic volume.
Cardiac catheterisation may reveal a classical square root sign pattern on the 
right ventricular trace. This is because right ventricular pressures drop rapidly in 
early diastole which causes a “dip” in the trace as a small amount of blood enters the 
right ventricle. The limit of RV distensibility is quickly reached because of constric-
tion by the rigid pericardium. Rapid equalisation of right atrial, right ventricular 
and pulmonary wedge pressures occurs, and blood flow across the tricuspid valve 
ceases abruptly causing a “plateau” in the pressure tracing (Figure 2).
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Kussmaul and Vaitkus were the first to delineate criteria for correctly diagnosing 
CP in patients on whom cardiac catheterisations were performed. They identified three 
criteria that could be used in the diagnosis: a left and right ventricular end-diastolic 
pressure difference of <5 mmHg, a ratio of right ventricular end-diastolic pressures to 
right ventricular systolic pressures of >1.3 and a right ventricular systolic pressure of 
<50 mmHg. If all three criteria are present and patients have clinical features in keep-
ing with the condition, CP will be correctly diagnosed in >90% of patients [49].
3.6.3 Medical management for constrictive pericarditis
Medical management is focused on the underlying cause of the pathology and 
may include diuretics, digoxin and beta-blockers to decrease venous congestion 
and tachyarrhythmias pre-operatively [9, 12, 46, 47, 49]. In the cases of TB pericar-
ditis, anti-tuberculous chemotherapeutic treatment is required for a minimum of 
2 months before surgery but can be continued for up to 12 months pre-operatively.
3.6.4 Differentiating constrictive pericarditis (CP) from restrictive cardiomyopathy (RC)
Many of the features of CP can also be found in RC making the diagnosis dif-
ficult [4, 6, 9, 12]. Restrictive cardiomyopathy is an intrinsic myocardial disease 
resulting in impaired relaxation and reduced compliance of cardiac chambers with 
severe diastolic dysfunction and atrial hypertension. Causes include infiltrative 
disorders such as amyloidosis, haemosiderosis and sarcoidosis or endomyocardial 
fibroelastosis found in scleroderma, radiotherapy or idiopathic disease.
The most important differentiating features in CP are the uncoupling of intra-
thoracic and intracardiac pressures and the increased ventricular interdependence. 
In RC, normal respiratory variation will be found on the CVP tracing. Conduction 
defects are also more common in patients with RC.
Differentiating features can also be elicited on TTE investigation [12]. E wave 
velocities reflecting early diastolic filling are reduced in RC because the intrinsic 
myocardial disease affects ventricular filling throughout the whole of diastole. 
Transmitral inflow velocity variation and respiratory variation in pulmonary vein 
flows are rarely found in RC. Atrial enlargement is marked reflecting severe atrial 
hypertension. Left ventricular hypertrophy is a common finding, and pericardial 
thickness will be normal. Pericardial calcifications will be absent in RC.
Figure 2. 
Right ventricular pressure tracings: pulmonary capillary wedge pressure, pulmonary artery pressure, right 
ventricular pressure and right atrial pressure with diastolic equalisation of pressures and sharp “y-dip” in the 
case of CP [46].
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4. Anaesthetic management
4.1 Pericardial effusions and tamponade
4.1.1 Pre-operatively
Accumulation of fluid in the pericardial space is the primary problem, and 
therefore definitive drainage and relief of the raised intra-pericardial pressure 
are required [9, 12, 21, 22, 32]. The type of drainage procedure will depend on the 
aetiology of the pericardial effusion and the clinical condition of the patient. A 
multidisciplinary team approach is needed, and a thorough pre-operative workup 
should be done if time allows. Clinical history and examination should be carried 
out focusing on pertinent physiological symptoms and signs to identify the cause 
and severity of the pathology.
Patients fall broadly into two categories: pericardial effusion with pre- 
tamponade physiology and a haemodynamically stable clinical picture or features of 
tamponade are present on TTE with haemodynamic consequences and instability. 
The presence of orthopnoea and pulsus paradoxus is a sign of a severely compro-
mised patient.
If there is haemodynamic compromise, the safest and quickest drainage option 
needs to be selected. Haemodynamic goals pre-drainage should follow the “Airway, 
Breathing, Circulation” approach bearing in mind the pathophysiology of tam-
ponade as discussed above. If required, a definitive airway management strategy 
should be employed and supplemental oxygen administered in order to optimise 
the delivery of oxygen to tissues during the decreased cardiac output state. Positive 
pressure ventilation should be avoided, but if required, peak airway pressures and 
PEEP should be minimised to avoid precipitation of cardiovascular collapse.
Large-bore peripheral access is needed for fluid and blood product administra-
tion and should be secured before any pharmacological agents are administered. 
Invasive arterial and central venous lines are needed for monitoring but should not 
delay drainage for patients in extremis.
Optimisation of preload is advised pre-operatively as hypovolaemia will worsen 
tamponade physiology. Dynamic measures of fluid responsiveness should be used 
to guide fluid therapy. A single, individualised fluid challenge may be beneficial, 
and outcome-based measures should be used to assess response. Improvement will 
be if the patient reports relief of symptoms or markers of end-organ perfusion 
improve.
Caution needs to be exercised as too much fluid will worsen the ventricular 
interdependence and further compromise cardiac output. Volume loading pre-
drainage may also exacerbate volume overload post-drainage. Temporary haemo-
dynamic support with a vasopressor agent may be more appropriate than excessive 
fluid administration to maintain blood pressure in the pre-operative period.
4.1.2 Types of drainage procedures
Needle pericardiocentesis consists of percutaneous placement of a catheter into 
the pericardial sac to facilitate external drainage of the effusion [24, 25]. Specific 
anatomical landmarks with echocardiographic and/or fluoroscopic guidance are 
used to insert the catheter using a Seldinger technique. This can be done in an awake 
patient with supplemental local anaesthetic and is the treatment of choice for an iat-
rogenic tamponade caused in the interventional suite [38]. The subcostal approach 
is safest for a blind procedure in the emergency setting where TTE may not be avail-
able. The apical and parasternal approaches may also be used. Pericardiocentesis is 
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diagnostic and therapeutic as drained fluid can be sent for testing. It is the preferred 
method of drainage in hypotensive patients.
Percutaneous balloon pericardiotomy is performed in a similar manner to 
TTE-guided pericardiocentesis and is effective in patients with malignant effusions. 
A balloon is used to generate a pericardial window to prevent recurrence of the 
tamponade.
Surgical procedures include a pericardial window performed via a substernal 
approach. Anterolateral thoracotomy and video-assisted thoracoscopic approaches 
may also be used. Surgical drainage allows for the formation of a pleuropericardial 
window which allows ongoing drainage of the effusion and decreases the risk of 
recurrent tamponade. Surgical drainage is preferred for haemopericardium, puru-
lent effusions and recurrent disease. The sub-xiphoid approach consists of a small 
sub-xiphoid incision made to relieve pressure and directly visualise the parietal 
pericardium. The advantages of this approach include its effectiveness and simplic-
ity and that it can be performed under local anaesthesia if needed for the patient 
nearing cardiovascular collapse.
4.1.3 Complications of drainage procedures
Needle pericardiocentesis under ultrasound guidance is considered a life-saving 
procedure with morbidity rates of 1–3% and a mortality rate of <1% [21, 41, 42, 50].
Puncture and/or rupture of myocardium or coronary vessels; arrhythmias; 
myocardial infarction; subsequent infection or damage to surrounding structures 
such as the stomach, liver or lung; and re-accumulation are some of the rare 
complications.
In the case of a loculated effusion, the pericardiocentesis may not be effective in 
relieving the chamber compression, and more definitive surgery may be needed.
Paradoxical haemodynamic deterioration following relief of pericardial tampon-
ade is sometimes encountered because of vasovagal effects with decreases in blood 
pressure and heart rate.
Pericardial decompression syndrome [21, 50] is defined as an unexpected decline in 
haemodynamic parameters associated with pulmonary oedema and global LV dys-
function. It usually occurs following surgical drainage of large, chronic effusions, 
but the incidence is rare <5%, and in most patients, there is no discernible reason 
for the ventricular dysfunction observed. The cause is unknown but may be related 
to increased interventricular interdependence. The sudden increase in preload and 
ventricular filling causes an abrupt increase in systolic wall stress, myocardial stun-
ning and volume overload with acute left ventricular failure. Sudden increases in 
left ventricular end-diastolic pressures are transmitted to the pulmonary circulation 
with increases in pulmonary pressures and extravasation of fluid into the alveoli 
leading to pulmonary oedema.
4.1.4 Anaesthetic techniques
All patients require adequate peripheral access and standard ASA monitoring 
prior to any anaesthetic agent being administered [12, 21, 22, 32, 49, 51–54]. It may 
also be necessary to institute invasive monitoring via arterial and central venous 
lines when appropriate, ensuring that insertion of the lines does not delay definitive 
treatment.
The anaesthetic technique chosen will depend on the clinical condition and hae-
modynamic stability of the patient, any concomitant co-morbidities, the aetiology 
of the effusion and the procedure being performed. There are some advantages to 
performing general anaesthesia over local anaesthesia and sedation. Patient comfort 
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is improved, surgical and operating conditions are optimised and TOE may be 
employed to guide surgery and ensure adequate evacuation of the effusion [21].
Regardless of the technique chosen, the following haemodynamic goals should 
be adhered to increase cardiac output, maintain heart rate, maintain sinus rhythm, 
maintain systemic vascular resistance and left ventricular afterload as tamponade is 
a fixed output state and ensure an appropriate ventilatory strategy to decrease right 
atrial and pulmonary pressures. This will augment right atrial filling and decrease 
right ventricular afterload to promote forward flow through the lungs and maintain 
left-sided filling pressures from the pulmonary veins.
Local anaesthetic infiltration with supplemental sedation using ketamine, 
midazolam or fentanyl may be sufficient for pericardiocentesis and sub-xiphoid 
windows in the less stable patients who are co-operative. Midazolam is a potent, 
short-acting benzodiazepine that may be used to facilitate drainage procedures 
under local anaesthesia. Doses of 0.01–0.03 mg/kg may be given slowly and titrated 
to effect. Respiratory depressant effects are exaggerated with concomitant adminis-
tration of opioids and other central nervous system depressant drugs.
If general anaesthetic is required, haemodynamic goals remain the same as 
above. Supplemental administration of fluid and/or blood products with vasopres-
sor or inotropic infusions may be required to support cardiac output.
4.1.4.1 Intraoperatively
Induction of anaesthesia may be associated with severe hypotension and subse-
quent cardiovascular collapse. The suppression of sympathetic drive from induc-
tion agents such as propofol or thiopentone causes vasodilation and bradycardia. 
Coupled with the deleterious effects of mechanical ventilation as described above, 
induction of anaesthesia may cause cardiovascular collapse in patients at risk.
The avoidance of respiratory depressant drugs and positive pressure ventilation 
should be the technique of choice if possible. Spontaneous respiration with a vola-
tile agent such as sevoflurane is ideal if tolerated by the patient. Conditions which 
may preclude inhalational induction include significant aspiration risk, morbid 
obesity, severe orthopnoea or an unco-operative patient [12].
Sevoflurane is a fluorinated methyl isopropyl ether anaesthetic agent that is non-
pungent, causes minimal airway irritation and is well tolerated by awake, sponta-
neously breathing patients. It causes a dose-dependent decrease in mean arterial 
pressure by causing vasodilation and reducing systemic vascular resistance. At 
concentrations of more than 1.5 minimum alveolar concentration (MAC), increases 
in heart rate may occur. Nominal changes in cardiac output and stroke volume occur 
with careful titration. Infusions of vasopressor agents may be required to maintain 
blood pressures while acquiring adequate depth of anaesthesia with a volatile agent. 
Adequate depth of anaesthesia should be confirmed before any attempts at manipu-
lation of the airway.
IV induction can be used for more stable patients with no evidence of tampon-
ade. Surgical preparation and draping to facilitate emergency drainage is advisable 
if IV induction is to be used. IV induction agents need to be carefully selected. 
Ketamine and etomidate are recommended agents of choice as they will have the 
least vasodilatory effects.
Ketamine is a phencyclidine derivative that induces a dissociative anaesthetic 
state. The cardiovascular effects mimic those of sympathetic nervous system 
stimulation. Systemic blood pressure, heart rate and cardiac output are all increased 
after intravenous induction doses of 1–2 mg/kg which satisfy the haemodynamic 
goals required in patients with tamponade pathophysiology. Although there is a 
theoretical concern about increases in right ventricular afterload with ketamine, it 
19
Anaesthesia for Patients with Pericardial Disease
DOI: http://dx.doi.org/10.5772/intechopen.82540
has been used safely in patients for both adjunctive sedation and general anaesthe-
sia. Critically ill patients may respond with unexpected decreases in blood pressure 
and cardiac output, reflecting a depletion of catecholamine stores and the unmask-
ing of ketamine’s direct myocardial depressant effects. Caution must therefore be 
exercised with these patients. In this instance, it may be more appropriate to use 
local anaesthesia with supplemental sedation doses of ketamine instead.
Etomidate is a unique carboxylated imidazole-containing compound that exerts 
its anaesthetic effect by binding to the GABAA receptor and enhancing GABA 
binding. Myocardial depressant effects are minimal and contractility is preserved. 
Nominal changes in heart rate, stroke volume and cardiac output are noted after 
induction doses of 0.3 mg/kg. This superior cardiovascular stability profile makes 
etomidate the recommended IV induction agent for patients with little or no 
cardiovascular reserve.
Propofol is a substituted isopropyl phenol which causes rapid onset of anaesthesia 
at induction doses of 1.5–2.5 mg/kg when administered intravenously. Its mechanism 
of action is to modulate GABA receptors causing hyperpolarisation and inhibition of 
the postsynaptic cell membrane. Propofol causes decreases in systemic vascular resis-
tance, negative inotropy and bradycardia. Vasodilation is mediated by the activation 
of protein kinase C, increased concentrations of nitric oxide and calcium channel-
blocking effects at a cellular level. This effect is present on both sides of the vascular 
system with arterial- and veno-dilation causing decreases in preload and afterload. 
Propofol has a depressant effect on the heart rate by decreasing the baroreceptor 
response to a drop in blood pressure [51]. These effects are exaggerated in patients 
with tamponade, and the use of propofol at induction doses is not recommended.
Potent opioid agonists, such as fentanyl, are recommended for use in varying 
doses for both sedation and anaesthesia in patients with cardiac tamponade coming 
for drainage procedures. They exhibit superior cardiac stability when compared 
with morphine and are useful adjuncts to provide analgesia and reduce the dose of 
narcotics required.
Inotropic and vasopressor support should be anticipated, immediately available 
and used as needed to maintain haemodynamic goals at induction of anaesthesia. 
The positive inotropic effects of catecholamine-enhancing drugs may be limited in 
patients with tamponade [32]. This may be because patients are already operating at 
maximum sympathetic stimulation as a compensatory mechanism for the low car-
diac output state. The choice of inotropic agent will depend on the patient’s clinical 
condition. Those agents with inodilator properties may improve coronary perfusion 
initially, but no increase in other organ perfusion has been shown. Caution should 
be exercised and drugs titrated in at low doses with continuous assessment of 
haemodynamic response. Vasopressor agents are useful to maintain afterload but 
should be avoided in patients with normal blood pressure as their use may cause 
further decreases in cardiac output.
4.1.5 Airway management
Securing a definitive airway early and in the safest way possible is recom-
mended. Endotracheal intubation allows for adequate control of ventilation and 
oxygenation. Mechanical ventilation may increase right ventricular afterload and 
decrease forward flow through the right ventricular outflow tract. This will in turn 
increase right ventricular end-diastolic pressures, worsen interventricular septal 
shift, further compromise left ventricular filling and negatively impact cardiac 
output. With an appropriate ventilatory strategy, however, the effect of mechanical 
ventilation can be minimised. The lowest possible inspiratory pressures and PEEP to 
maintain minute volume and oxygenation should be used [21].
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The choice of endotracheal tube will depend on the procedure. For example, 
one-lung ventilation may be needed to facilitate surgery in thoracotomy and video-
assisted thoracoscopic surgery (VATS). The time taken to insert a double-lumen 
tube and check its position may be detrimental in an unstable patient. Under these 
circumstances, placing a single-lumen tube with a bronchial blocker may be more 
appropriate.
If the patient is very unstable, the safest option may be to perform a sub-xiphoid 
window initially under local anaesthetic to relieve the tamponade. General anaes-
thesia may then be more safely induced.
4.1.6 Maintenance of anaesthesia
General anaesthesia care including intraoperative acid–base management, 
correction of electrolyte abnormalities, temperature and glucose control is required 
as for all high-risk patients coming for a procedure. These patients may present in a 
decompensated state which negates pre-operative optimisation of their condition. 
In the case of any emergency surgery, ongoing resuscitation is required even after 
the patient has been safely anaesthetised.
IV opioids, propofol, ketamine and volatile agents can all be used if they are 
tolerated and the haemodynamics remain stable. Careful titration of agents rather 
than specified doses should be employed. Muscle relaxants should only be used 
once the patient can tolerate positive pressure ventilation. The choice of neuro-
muscular-blocking agent will depend on the onset and duration of action required. 
The newer agents from both the aminosteroid and benzylisoquinoline groups of 
intermediate-acting neuromuscular-blocking agents are appropriate as they do not 
exhibit significant cardiovascular effects.
Continuous infusions of inotropes and pressors may be needed and must be 
continued on a case-by-case basis.
Because of surgical handling of the heart, intraoperative arrhythmias are com-
mon and should be anticipated. A defibrillator and antiarrhythmic drugs should 
be immediately available and standard Advanced Cardiac Life Support (ACLS) 
algorithms employed to manage peri-operative arrhythmias.
Transfusion triggers and the need for intraoperative administration of blood and 
clotting factors should be discussed and decided by the multidisciplinary team before 
induction. Ongoing fluid and blood product resuscitation may be required. Adequate 
haemoglobin levels to ensure optimal oxygen-carrying capacity is needed and should 
be individualised per case. Peri-operative monitoring of the patient’s coagulation 
status with thromboelastography (TEG) is advised in order to guide targeted admin-
istration of plasma products and pharmacological agents that may be required.
Because intrinsic myocardial function is generally preserved in pericardial 
effusion and tamponade, once the tamponade is relieved, there is usually a dramatic 
improvement in haemodynamics. At this point, vasopressor and inotropic infusions 
should be reviewed and weaned if appropriate. The use of vasodilator therapy is 
controversial and only indicated if there is associated systemic hypertension and 
elevated systemic vascular resistance [32].
4.1.6.1 Post-operatively
Patients should be transferred to a high-dependency unit for continuation 
of care. Ongoing monitoring is necessary to assess for recurrence of tampon-
ade, ongoing bleeding and continuation of cardiovascular and ventilatory 
support.
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4.2 Pericardiectomy for constrictive pericarditis
Pericardiectomy is the only definitive treatment for established constriction, and 
most studies suggest that resection should be as complete as technically feasible  
[49, 54–57]. A retrospective review by Nozohoor et al. showed that radical pericardiec-
tomy was associated with improved functional status and 10-year survival rates of 94% 
compared to 55% with subtotal pericardiectomy [55]. Bozbuga et al. also showed that 
performing early radical resection in combination with appropriate chemotherapeutic 
agents translated into the best outcomes in patients with tuberculous disease [56].
4.2.1 Types of pericardiectomy
Pericardial stripping is carried out via sternotomy or lateral thoracotomy with or 
without cardiopulmonary bypass support [49]. Total resection is extremely difficult 
to perform via a thoracotomy, and median sternotomy is the preferred approach to 
provide definitive resection and optimise benefit [49, 55].
Partial pericardiectomy is defined as incomplete decortication of one or both 
ventricles because of severe myo-pericardial adhesions.
Total pericardiectomy is when wide excision of the pericardium is performed. The 
anatomical borders consist of the phrenic nerves posteriorly, the great vessels and 
intra-pericardial portion of the superior vena cava/right atrial junction superiorly 
and the diaphragm and inferior vena cava/right atrial junction inferiorly.
Radical resection is the removal of the pericardium including the anterolateral 
and diaphragmatic surfaces of the left and right ventricles with careful dissection 
posterior to the phrenic nerves to leave the left and right phrenic pedicles intact.
Epicardial involvement may be missed at surgery leading to persistent constric-
tive physiology post-operatively. Reoperation to remove the diseased epicardium or 
visceral pericardium may be required [49].
The need for cardiopulmonary bypass (CPB) should be individualised per case. 
Studies suggest that mortality rates are higher in patients who required CPB, but data 
may be skewed because its use is usually reserved for patients with a poor pre-operative 
status. Other indications include any coexisting cardiac conditions that may require 
intervention, previous cardiac surgery or partial pericardiectomy, a heavily calcified 
pericardial “cocoon” encasing all four cardiac chambers, post mediastinal irradiation 
and unintentional surgical damage to cardiac structures intraoperatively [49].
Persistent constrictive physiology and abnormal diastolic filling patterns may 
be seen in a percentage of patients even after successful surgery. In conjunction 
with symptomatic improvement, normalisation of pressure-volume loops and 
echocardiographic findings post pericardiectomy are used as markers of successful 
resection [49, 58].
4.2.2 Complications associated with pericardiectomy
Pericardiectomy is a very technically challenging operation with significant mor-
bidity and mortality performed in high-risk patients [49, 54–57, 59]. Intraoperative 
complications may contribute significantly to poor outcomes. Sufficient pre- 
operative preparation prior to induction of anaesthesia is paramount to ensuring 
patient safety, and a multidisciplinary team approach should be used.
Massive haemorrhage should be anticipated with contingency plans in place 
before the administration of any anaesthetic agents. Timeous activation of a mas-
sive transfusion protocol is necessary. Cardiopulmonary bypass support should be 
immediately available with cannulation of femoral vessels under local anaesthesia 
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in select patients with severe or decompensated disease. Appropriate IV access and 
invasive monitoring should be established, and inotropic or vasopressor infusions 
drawn up and running at the time of induction of anaesthesia. Damage to underly-
ing epicardium, myocardium and coronary vessels poses the most risk to patients 
contributing to an overall mortality of about 7–18% [4]. Arrhythmias are common 
and prompt management as per the latest ACLS guidelines.
Low cardiac output syndrome, defined as a cardiac index of <2.2 l/min/m, will 
result in a subset of patients with chronic constrictive pericarditis [49, 60]. This is 
a form of acute cardiac failure, and there are a number of suggested mechanisms. 
The underlying myocardium may be affected by prolonged constriction caus-
ing myocardial disuse atrophy; residual constriction from partial or incomplete 
removal of the epicardial layer results in persistent constriction; the disease 
process itself may affect the myocardium; prolonged abnormal diastolic filling 
leads to architectural changes with remodelling of the ventricles; worsening of 
tricuspid regurgitation with progressive right ventricular dysfunction causes vol-
ume overload and right ventricular failure; and elongation of the papillary muscles 
leads to significant mitral regurgitation and left ventricular failure post relief of 
the constriction.
The incidence of low cardiac output syndrome post pericardiectomy is 28% 
with an associated mortality rate of up to 70% [60, 61]. Patients demonstrating 
prolonged symptomatic disease are at greatest risk [60]. This complication should 
be anticipated peri-operatively and managed with the appropriate haemodynamic 
and ventilatory support. Some studies suggest that levosimendan may be a pharma-
cological agent of choice [60].
4.2.3 Anaesthetic management
Intraoperative haemodynamic goals are to maintain heart rate, maintain 
systemic vascular resistance, optimise venous return and support myocardial 
contractility [12, 21, 22, 32, 49, 51–54, 60]. General anaesthesia care including 
intraoperative acid–base management, correction of electrolyte abnormalities, 
temperature and glucose control is required and will apply to these patients as 
mentioned above for pericardial tamponade.
Because CP is a fixed output state, patients have an increased reliance on heart 
rate and systemic vascular resistance to maintain systolic blood pressures and organ 
perfusion. Optimisation of preload and venous return preinduction are important 
to compensate for the decreased filling of the cardiac chambers. The consequences 
of possible fluid overload must always be considered, and these patients require 
dynamic assessment of fluid status as they too operate at the lower end of the 
Frank-Starling curve. This places them at increased risk for volume overload and 
low cardiac output syndrome, especially after relief of the constriction.
A balanced anaesthetic technique ensuring haemodynamic goals is necessary 
to avoid sudden decompensation at induction of anaesthesia [54, 60]. Ketamine 
is often recommended as the anaesthetic induction agent of choice because of its 
sympathomimetic effects on the cardiovascular system. Midazolam, etomidate and 
potent opioids such as fentanyl have also been safely used for induction of anaesthe-
sia. Securing a definitive airway is recommended, and the use of muscle relaxants 
can be used early on, bearing in mind the possible deleterious effects of mechanical 
ventilation. The institution of positive pressure ventilation may compromise right 
heart chamber filling, and appropriate settings are needed to optimise ventilation, 
oxygenation and haemodynamics.
It is highly recommended that inotropic and/or vasopressor infusions are drawn 
up and running at the time of induction. These should be continued and titrated 
23
Anaesthesia for Patients with Pericardial Disease
DOI: http://dx.doi.org/10.5772/intechopen.82540
throughout surgery and continued into the post-operative period in anticipation for 
a persistent low cardiac output state, especially in at-risk patients.
Anticipation for massive blood loss, both acute and ongoing, is of vital impor-
tance as mentioned above. Monitoring with heightened intraoperative vigilance, 
regular blood gas and TEG analysis will guide transfusion of blood, clotting factors 
and pharmacological agents that may be required.
Damage to cardiac structures may lead to massive sudden haemorrhage, myo-
cardial ischaemia or significant arrhythmias. Appropriate management must be 
instituted immediately and may include the need for cardiopulmonary bypass if 
conventional surgical and medical management fail.
The need for elective cardiopulmonary bypass support will depend on the 
pre-operative condition of the patient, the aetiology of the CP and the underly-
ing myocardial function. The decision for the adjunctive use of bypass should be 
discussed and decided upon during the multidisciplinary team discussion prior to 
surgery. If deemed necessary, the femoral vessels should be prepped and cannulated 
under local anaesthesia prior to induction of anaesthesia.
Post-operatively, patients should be transferred to a high-dependency unit for 
continuation of care. Ongoing monitoring for persistent bleeding and low cardiac 
output syndrome is necessary as well as ongoing haemodynamic and ventilatory 
support.
4.2.4 Predictors of outcome following pericardiectomy
Early post-operative mortality rates are in the region of 18% [46, 49, 56, 57, 59]. 
Peri-operative mortality is highly dependent on the patient’s pre-operative NYHA 
status [56].
Predictors of poor long-term outcome include the aetiology of the disease, 
previous radiation, renal dysfunction, hyponatraemia, old age, low pre-operative 
left ventricular ejection fraction, right ventricular dilatation, elevated pulmonary 
pressures and the severity of tricuspid regurgitation [46, 49, 57, 59].
Because of the high peri-operative morbidity and mortality, patients with mild 
or very advanced disease, renal failure or post-radiation constrictive pericarditis 
should be evaluated very carefully pre-operatively as the risk of pericardiectomy 
may outweigh the benefits.
5. Conclusion
Patients with pericardial disease can be challenging for the attending anaesthe-
siologist. An in-depth understanding of the pathophysiology of each disease state is 
necessary to provide optimal care. Careful pre-operative evaluation of the clinical 
history, examination and diagnostic investigations will allow adequate evaluation 
of risk and alert the anaesthesiologist to the necessary steps to be taken to manage 
these high-risk patients in the safest way possible.
An appreciation of how the chosen anaesthetic technique may influence 
the patient’s haemodynamic state is necessary to avoid unwanted anaesthetic 
complications. This includes a thorough understanding of the effect of pharma-
cological agents as well as how mechanical ventilation may influence haemody-
namics. The potential risk and complications of the surgical procedure should 
be examined and discussed with the multidisciplinary team pre- 
operatively in order to ensure adequate preparation for any potentially cata-
strophic events. These patients are best cared for by experienced peri-operative 
teams who have this appreciation.
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